BRIEF published on 06/27/2024 at 07:05, 2 years 4 months ago SCHOTT Pharma Reports Robust Growth in Q2 of Fiscal Year 2024 Global Expansion Revenue Growth SCHOTT Pharma Q2 2024 High-value Solutions
BRIEF published on 06/27/2024 at 07:05, 2 years 4 months ago SCHOTT Pharma annonce une croissance robuste au deuxième trimestre de l'exercice 2024 SCHOTT Pharma Expansion Mondiale Solutions À Haute Valeur Ajoutée Hausse Des Revenus T2 2024
PRESS RELEASE published on 06/27/2024 at 07:00, 2 years 4 months ago SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024 SCHOTT Pharma reports 11% revenue growth in Q2 2024, reaffirms guidance for fiscal year. Focus on high-value solutions and expansion. Key figures and strategic developments outlined Financial Results Expansion Revenue Growth SCHOTT Pharma High-value Solutions
BRIEF published on 06/14/2024 at 13:03, 2 years 5 months ago SCHOTT Pharma Opens State-of-the-Art Production Facility in Hungary SCHOTT Pharma Pharmaceutical Trends Hungary Production Facility Glass Syringes
BRIEF published on 06/14/2024 at 13:03, 2 years 5 months ago SCHOTT Pharma ouvre une usine de production de pointe en Hongrie SCHOTT Pharma Usine Hongrie Seringues En Verre Tendances Pharmaceutiques
PRESS RELEASE published on 06/14/2024 at 12:58, 2 years 5 months ago Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary SCHOTT Pharma opens new production facility in Hungary, expanding prefillable glass syringe output to support pharma market growth and trends SCHOTT Pharma Pharma Industry Hungary Production Facility Prefillable Glass Syringes
BRIEF published on 05/14/2024 at 18:24, 2 years 6 months ago SCHOTT Pharma Reaffirms FY 24 Outlook, Anticipates Slower Growth in FY 25 Due to Reduced Syringe Demand Financial Results SCHOTT Pharma FY 24 Forecast FY 25 Growth Impact Syringe Demand Decrease
BRIEF published on 05/14/2024 at 18:24, 2 years 6 months ago SCHOTT Pharma réaffirme ses perspectives pour l’exercice 24 et prévoit un ralentissement de la croissance au cours de l’exercice 25 en raison de la réduction de la demande de seringues Résultats Financiers SCHOTT Pharma Prévisions Pour L'exercice 24 Impact Sur La Croissance Pour L’exercice 25 Diminution De La Demande En Seringues
PRESS RELEASE published on 05/14/2024 at 18:19, 2 years 6 months ago SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes SCHOTT Pharma confirms FY 24 outlook based on Q2 results; FY 25 impacted by slower growth from syringes. H1 24 revenues up 9% at constant currencies Revenue Growth SCHOTT Pharma Syringes FY 24 FY 25
BRIEF published on 05/14/2024 at 18:08, 2 years 6 months ago SCHOTT Pharma Anticipates Fiscal Year 2025 Impact Due to Slower Syringe Sales Revenue Growth EBITDA Margin SCHOTT Pharma Fiscal Year 2025 Syringe Demand
Published on 11/18/2026 at 00:35, 52 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 1 hour 47 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 2 hours 27 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 3 hours 57 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 10 hours 27 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/18/2026 at 00:59, 28 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 23:13, 2 hours 14 minutes ago EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%
Published on 11/17/2026 at 22:00, 3 hours 27 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 21:12, 4 hours 15 minutes ago EQS-Adhoc: JDC Group AG: Adjustment of Full-Year Guidance
Published on 11/17/2026 at 20:21, 5 hours 6 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 18:00, 7 hours 27 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 18:00, 7 hours 27 minutes ago Accor - Accor se renforce au capital de Ennismore
Published on 11/17/2026 at 17:45, 7 hours 42 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 17:45, 7 hours 42 minutes ago EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 17 hours 46 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.